University Health Network-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University Health Network - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013494
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University Health Network (UHN) is a health care institution that provides patient care, research and educational services, and patient support services. It offers health care services such as palliative care, pharmacy and telehealth. UHN also provides specialized program services, accessibility, health records, hospitality services and volunteer resources. The organization conducts research in the fields of neurosciences, cardiology, oncology, transplantation, surgical innovation, genomic medicine, infectious diseases, and rehabilitation medicine. UHN is a network of health care and teaching institutions, namely, Toronto General and Toronto Western Hospitals, the Princess Margaret Cancer Centre, Toronto Rehabilitation Institute and The Michener Institute of Education at UHN. It is a research hospital affiliated to the University of Toronto. UHN is headquartered in Toronto, Ontario, Canada.

University Health Network – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University Health Network, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University Health Network, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University Health Network, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University Health Network, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
University Health Network, Medical Devices Deals, 2011 to YTD 2017 10
University Health Network, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
University Health Network, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
DLVR Therapeutics Secures Additional Investment In Seed Financing 12
Partnerships 13
Theralase Technologies Expands its Research Agreement with University Health Network 13
OncoTherics Enters into Agreement with University Health Network 14
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 15
Licensing Agreements 16
VistaGen Therapeutics Enters into Licensing Agreement with University Health Network 16
VistaGen Therapeutics Enters Licensing Agreement with University Health Network 17
Sernova Enters into Licensing Agreement with University Health Network 18
Avrobio Enters into Licensing Agreement with University Health Network 19
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 20
Stem Cell Therapeutics Enters into Licensing Agreement with University Health Network 21
University Health Network – Key Competitors 22
University Health Network – Key Employees 23
University Health Network – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Government and Public Interest 25
Nov 23, 2017: Innovative Medicines Canada and Astellas Announce Grant to the University Health Network’s Transplant Innovation Fund 25
Nov 15, 2017: Molecular pathway offers treatment targets for pulmonary fibrosis, related conditions 26
Nov 06, 2017: UHN Vision Scientists Discover Potential Neuroprotective Treatment For Glaucoma 28
Oct 13, 2017: Neurotechnological innovation and organ-on-a-chip engineering centres receive more than $10 million in new funding 29
Nov 08, 2016: Blocking the Formation of a Cancer in the Brain 30
Aug 29, 2016: Breast cancer Researchers Look Beyond Genes to Find More Drivers of Disease Development 31
Aug 04, 2016: Research team discovers two biomarkers that contribute to spine osteoarthritis 32
Jul 14, 2016: Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood 33
Jul 14, 2016: Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood for future clinical use 34
Jun 28, 2016: Prostate cancer researchers use liquid biopsy biomarkers to identify aggressive disease before treatment 35
Apr 19, 2016: Breast cancer patients receiving Herceptin treatment should be monitored for heart damage at any age 36
Jan 07, 2016: Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario 37
Product News 38
Feb 06, 2017: Immune therapy scientists discover distinct cells that block cancer-fighting immune cells 38
Other Significant Developments 39
Apr 12, 2017: University Health Network: First-of-its-kind app offers personalized rehab therapy for stroke patients 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
University Health Network, Pharmaceuticals & Healthcare, Key Facts 2
University Health Network, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University Health Network, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University Health Network, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University Health Network, Deals By Therapy Area, 2011 to YTD 2017 9
University Health Network, Medical Devices Deals, 2011 to YTD 2017 10
University Health Network, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
DLVR Therapeutics Secures Additional Investment In Seed Financing 12
Theralase Technologies Expands its Research Agreement with University Health Network 13
OncoTherics Enters into Agreement with University Health Network 14
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 15
VistaGen Therapeutics Enters into Licensing Agreement with University Health Network 16
VistaGen Therapeutics Enters Licensing Agreement with University Health Network 17
Sernova Enters into Licensing Agreement with University Health Network 18
Avrobio Enters into Licensing Agreement with University Health Network 19
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 20
Stem Cell Therapeutics Enters into Licensing Agreement with University Health Network 21
University Health Network, Key Competitors 22
University Health Network, Key Employees 23
University Health Network, Subsidiaries 24

★海外企業調査レポート[University Health Network-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EnerVest Ltd:企業のM&A・事業提携・投資動向
    EnerVest Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnerVest Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Forma Therapeutics Inc:企業のM&A・事業提携・投資動向
    Forma Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Forma Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Williams-Sonoma, Inc.:戦略・SWOT・企業財務分析
    Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report Summary Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AT&T Inc:戦略・SWOT・企業財務分析
    AT&T Inc - Strategy, SWOT and Corporate Finance Report Summary AT&T Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Whiting Petroleum Corporation:企業の戦略・SWOT・財務情報
    Whiting Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Whiting Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Den-Mat Holdings LLC:医療機器:M&Aディール及び事業提携情報
    Summary Den-Mat Holdings LLC (Den-Mat) is a medical device company that manufactures and develops dental and related products. The company’s products include consumables, small equipment, and a full-service dental laboratory. Its consumables comprise geristore, core paste, tenure, ultra-bond, plashm …
  • Mahindra & Mahindra Ltd (M&M):企業の財務・戦略的SWOT分析
    Mahindra & Mahindra Ltd (M&M) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Medical Developments International Ltd (MVP):企業の財務・戦略的SWOT分析
    Summary Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company provides products such as penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products whic …
  • American Bridge Company:企業の戦略・SWOT・財務分析
    American Bridge Company - Strategy, SWOT and Corporate Finance Report Summary American Bridge Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Semiconductor Manufacturing International Corporation:企業のM&A・事業提携・投資動向
    Semiconductor Manufacturing International Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Semiconductor Manufacturing International Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes busin …
  • ADAMA Agricultural Solutions Ltd.:企業の戦略的SWOT分析
    ADAMA Agricultural Solutions Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Belize Electricity Ltd:発電所・企業SWOT分析
    Belize Electricity Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • Exact Sciences Corp (EXAS):企業の財務・戦略的SWOT分析
    Exact Sciences Corp (EXAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • China Mobile Ltd (941):企業の財務・戦略的SWOT分析
    China Mobile Ltd (941) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Hanwha Q CELLS Co Ltd (HQCL):企業の財務・戦略的SWOT分析
    Hanwha Q CELLS Co Ltd (HQCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • San Miguel Brewery Inc:企業の戦略・SWOT・財務情報
    San Miguel Brewery Inc - Strategy, SWOT and Corporate Finance Report Summary San Miguel Brewery Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Senju Pharmaceutical Co Ltd:企業の戦略的SWOT分析
    Senju Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Enel Americas SA:企業の戦略・SWOT・財務情報
    Enel Americas SA - Strategy, SWOT and Corporate Finance Report Summary Enel Americas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • GVK Power and Infrastructure Ltd (GVKPIL):電力:M&Aディール及び事業提携情報
    Summary GVK Power and Infrastructure Ltd (GVKPIL), formerly Jegurupadu Operation & Maintenance Company Limited, is a diversified infrastructure company that operates across various sectors including energy, transportation, hospitality, resources, airports, and life sciences. It carries out construct …
  • La-Z-Boy Incorporated:企業の戦略・SWOT・財務分析
    La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report Summary La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆